Clough Capital Partners
Overview
Clough Capital Partners L.P. is a global multi-strategy alternative asset management firm founded in 1999 and based in Boston, MA . The firm employs fundamental research to invest in public and private markets, across various asset classes and manages an array of strategies for its clients . Clough Capital's investment strategy centers around identifying key, proprietary insights into industry or economic trends through fundamental research . This process aims to uncover information before it impacts the value of relevant securities, leading to attractive investment returns .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Centrexion Therapeutics | Jan 2018 | Series D | - |
| Amphivena Therapeutics | Sep 2019 | Series C | - |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Clough Capital Partners based?
Clough Capital Partners is headquartered in Boston, Massachusetts, United States.
When was Clough Capital Partners founded?
Clough Capital Partners was founded in 1999.
How many portfolio companies does Clough Capital Partners have?
Clough Capital Partners has 3 portfolio companies in Caplight's dataset.
What are some companies in Clough Capital Partners's portfolio?
Portfolio companies visible on Caplight include Centrexion Therapeutics, Amphivena Therapeutics.
What was Clough Capital Partners's most recent investment shown here?
Clough Capital Partners's most recent investment in this portfolio sample was in Amphivena Therapeutics in 2019.
What sectors does Clough Capital Partners focus on?
Clough Capital Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Clough Capital Partners focus on?
Clough Capital Partners typically invests at the Early stage.
What is Clough Capital Partners's AUM?
Clough Capital Partners's assets under management are estimated between $1.0B and $10.0B.